Update on status of FIRB approval and second court hearing
Filed with ASX · · 2 pages · English
Watch Mayne Pharma's latest callMayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call · Replay · Aug 26
Mayne Pharma Group Ltd. on 6ix
Story so far
Earlier from Mayne Pharma
- MYX Declaration of Unacceptable Circumstances and Orders
- Update on FIRB approval and Scheme
- MYX - Panel Conducts Proceedings and Makes Interim Orders
- Update on Scheme and Supreme Court of NSW proceedings
- MYX Scheme of Arrangement update on FIRB approval
Later from Mayne Pharma
- Pause in Trading
- Trading Halt
- Update on FIRB condition and scheme
- Mayne Pharma issues notice of intention to terminate the SID
- MYX receives purported termination notice from Cosette
Follow Mayne Pharma into a list and get an email when it puts out news.
Follow Mayne Pharma